Annual report
2540.TEDINET S100RF1N
Period2022-04-01 → 2023-03-31
Filed2023-07-18
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Amends S100R6KO. Amended by S100RF1Q (2023-07-18).
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.6bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥10.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥10.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥996m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥937m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥877m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥950m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥808m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥788m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥687m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥49.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥48.6bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥47.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥44.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥46.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.4bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥42.8bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥42.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥41.6bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥39.2bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥40.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.2bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥217m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥555m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥552m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥551m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥551m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥550m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥73.92 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.91 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.67 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.32 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.01 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥55 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,097.62 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,058.44 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,018.77 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,851.21 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,957.48 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 86.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 16,500,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,500,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,500,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,500,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,500,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 290 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 292 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 291 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 280 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 271 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥82m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥112m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥39.2bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥1.5bn |
| Kurasuwa Related Operationsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥144m |
| Kurasuwa Related Operationsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥9m |
| Kurasuwa Related Operationsreportable segment | employees | at 2023-03-31 | 77 pure |
| Kurasuwa Related Operationsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥955m |
| Kurasuwa Related Operationsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥955m |
| Kurasuwa Related Operationsreportable segment | segment assets | at 2023-03-31 | ¥356m |
| Kurasuwa Related Operationsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥222m |
| Yomeishu Related Operationsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥337m |
| Yomeishu Related Operationsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥392m |
| Yomeishu Related Operationsreportable segment | employees | at 2023-03-31 | 147 pure |
| Yomeishu Related Operationsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥9.7bn |
| Yomeishu Related Operationsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥9.7bn |
| Yomeishu Related Operationsreportable segment | segment assets | at 2023-03-31 | ¥10.0bn |
| Yomeishu Related Operationsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥481m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥401m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥10.6bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥10.6bn |
| —segment total | segment assets | at 2023-03-31 | ¥10.3bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,275
| Item | Context | Value | Unit |
|---|---|---|---|
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00400-000SunagaAkemiMember | Original text (Japanese)取締役監査等委員 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00400-000SunagaAkemiMember | Original text (Japanese)須 永 明 美 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00400-000SunagaAkemiMember | 1961-08-14 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00400-000SunagaAkemiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00400-000SunagaAkemiMember | Original text (Japanese)注４ | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | Original text (Japanese)取引先持株会の会員としての取得であります。 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)キッコーマン㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)食品分野における安定的な取引関係の維持・強化を目的に株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)ロート製薬㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)㈱三菱UFJフィナンシャル・グループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)安定的な財務基盤の確保を踏まえた取引関係の維持・強化を目的に株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)日本新薬㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)医薬品分野における取引・協力関係の構築による企業価値向上を図るため株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)小野薬品工業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)医薬品分野における取引・協力関係の構築による企業価値向上を図るため株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)ブルドックソース㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)食品分野における安定的な取引関係の維持・強化を目的に株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)㈱八十二銀行 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)安定的な財務基盤の確保を踏まえた取引関係の維持・強化を目的に株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)㈱Ｔ＆Ｄホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)安定的な財務基盤の確保を踏まえた取引関係の維持・強化を目的に株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)久光製薬㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)医薬品分野における取引・協力関係の構築による企業価値向上を図るため株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)キユーピー㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)食品分野における取引・協力関係の構築による企業価値向上を図るため株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)㈱ワコールホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)新規事業における取引・協力関係の構築による事業拡大・企業価値向上を図るため株式を保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)松田産業㈱ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |